A Brief Review on Dementia

Dementia is a cognition decline that interferes with daily life functions. It is a syndrome cause of dementia is neurological and some medical conditions. Sometimes other diseases can contribute to dementia. Dementias of the neurodegenerative kind are common in adults, while injury to brain and brain tumors are common in students. In recent years, there have been advancements in neuroimaging and the correlation of clinics with pathology, and in the development of biomarkers, doctors still await modifying therapies for neurodegenerative dichasia. There have been only a few articles on dementia within the IJP. Most of the patients found are above the age of 60. Therefore, community-based interventions for the management of diseases like dementia are essential. The effectiveness of those resolves must be acknowledged. Also, the danger factors for dementia should be identified. It is statically proved that folks will suffer from dementia more within the near future. Thus research during this field is significant for developing service and training. This paper aims to review research published on dementia in people above 40 years. The cases of dementia increase with the increase in age of the person. Dementia makes people more and more dependent on others. Dementia is increasing challenges to our society and healthcare system. Clinical and pathological criteria for the significant dementia-causing diseases overlap significantly. The emergence of symptoms decades into the pathophysiological process hamper targeted disease therapy. A significant number of research initiatives are underway to identify potential biomarkers of disease processes earlier. The association of both overt cognitive decline and underlying pathophysiological processes with normal aging complicates identifying disease processes early within the spectrum of normal aging. Once the diagnosis is established, prognostic measures are required and are still lacking, as disease trajectories between individuals can vary greatly. Globally, governments recognize these challenges. Investment and research infrastructure are beginning to reflect the scale of the need. Drugs conferring symptomatic benefit are available, and memory service structures exist to diagnose dementias and guide management. The personal impact of dementia on patients and families is also increasingly recognized, with discussion in the media surrounding famous sufferers and dramatizations in literature and film. Herein we attempt to describe the current landscape of dementia.